EUVIMED · CrossrefZeitschrift
Current Colorectal Cancer Reports
ISSN 1556-3790 · Springer Science and Business Media LLC
Neueste Artikel
Current Surgical Strategies in the Management of Rectal Cancer
Colorectal Cancer and Metabolism
Lifestyle after Colorectal Cancer Diagnosis in Relation to Survival and Recurrence: A Review of the Literature
WNT Signaling and Colorectal Cancer
NOTCH Signaling and ATOH1 in Colorectal Cancers
Colorectal Cancer Stem Cells: Biology and Therapeutic Implications
Web alert
Environmental risk factors and colorectal neoplasia: Recent developments
Basic concepts for genetic testing in common hereditary colorectal cancer syndromes
Molecular staging: Integration of molecular prognostic markers into staging of colon cancer
Individualized chemotherapy based on genetic and genomic profiling
Clinical significance of tumor microsatellite instability and immunohistochemistry for mismatch repair deficiency in colorectal cancers
Cancer screening guidelines and prevention factors for high-risk patients with a family history of colorectal cancer
Editor’s commentary: Introduction to the first issue
Web alert
Second-line therapy for advanced colorectal cancer
New developments in therapy for metastatic colorectal cancer
Using biologic markers to optimize therapies
Optimizing adjuvant therapy for colon cancer: Ongoing investigations
Chemotherapy in patients with resectable liver metastases from colorectal cancer
Advances in surgical technique for primary rectal cancer
Chemoradiation for localized rectal cancer: Neoadjuvant versus adjuvant approaches
The integration of biologic agents into the current systemic management of rectal cancer
Web alert
Molecular genetics of colorectal cancer: An overview
Chemoprevention of colorectal cancer by inhibition of cyclooxygenase-2 derived prostaglandin E2 signaling: Recent advances in basic biology
Genomic instability and colorectal cancer
Roles for transforming growth factor-α and transforming growth factor-ß in colorectal cancer
Neoadjuvant and adjuvant therapy combined with resection of hepatic colorectal cancer metastases
Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases
EUVIMED